Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer

Lignende værker

• Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
  af: Yang, Qiong, et al.
  Udgivet: (2015)
• Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
  af: Strickler, John H., et al.
  Udgivet: (2012)
• The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
  af: Yin, Chenxi, et al.
  Udgivet: (2016)
• Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
  af: Derangère, Valentin, et al.
  Udgivet: (2016)
• Second- and Third-Line Treatment Options for Unresectable Metastatic Colorectal Cancer
  af: Saltz, Leonard B.
  Udgivet: (2008)